Neurobiology of Aging
Volume 31, Issue 10 , Pages 1766-1773 , October 2010

Chlamydia pneumoniae infection enhances microglial activation in atherosclerotic mice

  • M. Voorend

      Affiliations

    • Department of Neurology, Cardiovascular Research Institute Maastricht (CARIM), University Hospital Maastricht, the Netherlands
    • Corresponding Author InformationCorresponding author at: Department of Neurology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, Netherlands. Tel.: +31 43 3875061; fax: +31 43 3877055.
    • ,
  • A.J.A.M. van der Ven

      Affiliations

    • Department of Internal Medicine, University Hospital Nijmegen, the Netherlands
    • ,
  • M. Mulder

      Affiliations

    • European Graduate School of Neuroscience (EURON), the Netherlands
    • Department of Genetics and Molecular Cellbiology, the Netherlands
    • ,
  • J. Lodder

      Affiliations

    • Department of Neurology, Cardiovascular Research Institute Maastricht (CARIM), University Hospital Maastricht, the Netherlands
    • ,
  • H.W.M. Steinbusch

      Affiliations

    • Department of Psychiatry and Neuropsychology, the Netherlands
    • European Graduate School of Neuroscience (EURON), the Netherlands
    • ,
  • C.A. Bruggeman

      Affiliations

    • Department of Medical Microbiology, Cardiovascular Research Institute Maastricht (CARIM), University Hospital Maastricht, the Netherlands

Received 16 October 2006 ,Revised 14 September 2008 ,Accepted 30 September 2008.

References 

  1. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, et al. Inflammation and Alzheimer's disease. Neurobiol. Aging. 2000;21:383–421
  2. Balin BJ, Gerard HC, Arking EJ, Appelt DM, Branigan PJ, Abrams JT, et al. Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med. Microbiol. Immunol. (Berl.). 1998;187:23–42
  3. Berger M, Schroder B, Daeschlein G, Schneider W, Busjahn A, Buchwalow I, et al. Chlamydia pneumoniae DNA in non-coronary atherosclerotic plaques and circulating leukocytes. J. Lab. Clin. Med. 2000;136:194–200
  4. Boelen E, Steinbusch HW, van der Ven AJ, Grauls G, Bruggeman CA, Stassen FR. Chlamydia pneumoniae infection of brain cells: an in vitro study. Neurobiol. Aging. 2006;28:524–532
  5. Breteler MM. Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol. Aging. 2000;21(2):153–160
  6. Buttini M, Appel K, Sauter A, Gebicke Haerter PJ, Boddeke HW. Expression of tumor necrosis factor alpha after focal cerebral ischaemia in the rat. Neuroscience. 1996;71:1–16
  7. Cochrane M, Pospischil A, Walker P, Gibbs H, Timms P. Distribution of Chlamydia pneumoniae DNA in atherosclerotic carotid arteries: significance for sampling procedures. J. Clin. Microbiol. 2003;41:1454–1457
  8. Cook PJ, Honeybourne D, Lip GYH, Beevers DG, Wise R, Davies AH. Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: the West Birmingham Stroke Project. Stroke. 1998;29:404–410
  9. Dreses-Werringloer U, Gerard HC, Whittum-Hudson JA, Hudson AP. Chlamydophila (Chlamydia) pneumoniae infection of human astrocytes and microglia in culture displays an active, rather than a persistent, phenotype. Am. J. Med. Sci. 2006;332(4):168–174
  10. Eikelenboom P, Bate C, Van Gool WA, Hoozemans JJ, Rozemuller JM, Veerhuis R, et al. Neuroinflammation in Alzheimer's disease and prion disease. Glia. 2002;40(2):232–239
  11. Elkind MS, Lin IF, Grayston JT, Sacco RL. Chlamydia pneumoniae and the risk of first ischemic stroke: the Northern Manhattan Stroke Study. Stroke. 2000;31:1521–1525
  12. Ezzahiri R, Nelissen Vrancken HJMG, Kurvers HAJM, Stassen FRM, Vliegen I, Grauls GELM, et al. Chlamydophila pneumoniae (Chlamydia pneumoniae) accelerates the formation of complex atherosclerotic lesions in Apo E3-Leiden mice. Cardiovasc. Res. 2002;56(2):269
  13. Ezzahiri R, Stassen FR, Kurvers HA, van Pul MM, Kitslaar PJ, Bruggeman CA. Chlamydia pneumoniae infection induces an unstable atherosclerotic plaque phenotype in LDL-receptor, ApoE double knockout mice. Eur. J. Vasc. Endovasc. Surg. 2003;26(1):88–95
  14. Gerard HC, Dreses-Werringloer U, Wildt KS, Deka S, Oszust C, Balin BJ, et al. Chlamydophila (Chlamydia) pneumoniae in the Alzheimer's brain. FEMS Immunol. Med. Microbiol. 2006;48(3):355–366
  15. Gonzales-Scarano F, Baltuch G. Microglia as mediators of inflammatory and degenerative diseases. Annu. Rev. Neurosci. 1999;219–240
  16. Grayston JT. Infections caused by Chlamydia pneumoniae strain TWAR [see comments]. Clin. Infect. Dis. 1992;15:757–761
  17. Hofman A, Ott A, Breteler MM, Bots ML, Slooter AJ, van Harskamp F, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet. 1997;349(9046):151–154
  18. Kalaria RN. The role of cerebral ischemia in Alzheimer's disease. Neurobiol. Aging. 2000;21(2):321–330
  19. Kuo CC, Jackson LA, Campbell LA, Grayston JT. Chlamydia pneumoniae (TWAR). Clin. Microbiol. Rev. 1995;8:451–461
  20. Little CS, Bowe A, Lin R, Litsky J, Fogel RM, Balin BJ, et al. Age alterations in extent and severity of experimental intranasal infection with Chlamydophila pneumoniae in BALB/c mice. Infect. Immun. 2005;73(3):1723–1734
  21. Little CS, Hammond CJ, MacIntyre A, Balin BJ, Appelt DM. Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice. Neurobiol. Aging. 2004;25(4):419–429
  22. MacIntyre A, Abramov R, Hammond CJ, Hudson AP, Arking EJ, Little CS, et al. Chlamydia pneumoniae infection promotes the transmigration of monocytes through human brain endothelial cells. J. Neurosci. Res. 2003;71(5):740–750
  23. Mulder M, Blokland A, van den Berg DJ, Schulten H, Bakker AH, Terwel D, et al. Apolipoprotein E protects against neuropathology induced by a high-fat diet and maintains the integrity of the blood–brain barrier during aging. Lab. Invest. 2001;81:953–960
  24. Persidsky Y. Model systems for studies of leukocyte migration across the blood–brain barrier. J. Neurovirol. 1999;5(6):579–590
  25. Qing Z, Sewell D, Sandor M, Fabry Z. Antigen-specific T cell trafficking into the central nervous system. J. Neuroimmunol. 2000;105:169–178
  26. Rassu M, Cazzavillan S, Scagnelli M, Peron A, Bevilacqua PA, Facco M, et al. Demonstration of Chlamydia pneumoniae in atherosclerotic arteries from various vascular regions. Atherosclerosis. 2001;158:73–79
  27. Roblin PM, Dumornay W, Hammerschlag MR. Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae. J. Clin. Microbiol. 1992;30:1968–1971
  28. Rogers J, Strohmeyer R, Kovelowski CJ, Li R. Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide. Glia. 2002;40(2):260–269
  29. Rosenberg GA, Sullivan N, Esiri MM. White matter damage is associated with matrix metalloproteinases in vascular dementia. Stroke. 2001;32(5):1162–1168
  30. Rosenfeld ME, Blessing E, Lin TM, Moazed TC, Campbell LA, Kuo C. Chlamydia, inflammation, and atherogenesis. J. Infect. Dis. 2000;181(Suppl. 3):S492–S497
  31. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 1988;2:983–986
  32. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease: the Nun Study. JAMA. 1997;277(10):813–817
  33. Tomimoto H, Akiguchi I. The role of immunologic reactions in the pathogenesis in Binswanger's disease: a clue to therapeutic approach. Rinsho Shinkeigaku. 1999;39:56–58
  34. Vink A, Poppen M, Schoneveld AH, Roholl PJ, de Kleijn DP, Borst C, et al. Distribution of Chlamydia pneumoniae in the human arterial system and its relation to the local amount of atherosclerosis within the individual. Circulation. 2001;103(12):1613–1617
  35. Virok D, Kis Z, Karai L, Intzedy L, Burian K, Szabo A, et al. Chlamydia pneumoniae in atherosclerotic middle cerebral artery. Stroke. 2001;32:1973–1976
  36. Warschkau H, Kiderlen AF. A monoclonal antibody directed against the murine macrophage surface molecule F4/80 modulates natural immune response to Listeria monocytogenes. J. Immunol. 1999;163:3409–3416
  37. Williams AE, Blakemore WF. Pathogenesis of meningitis caused by Streptococcus suis type 2. J. Infect. Dis. 1990;162(2):474–481

PII: S0197-4580(08)00359-X

doi: 10.1016/j.neurobiolaging.2008.09.022

Neurobiology of Aging
Volume 31, Issue 10 , Pages 1766-1773 , October 2010

Article Tools

* Image Usage & Resolution